Paige is revolutionizing the way pathologists work by bringing confidence to cancer diagnosis. Our novel AI applications support pathologists in each step of the diagnostic process, offering unrivalled insights to transform cancer care.
Our AI is built on one of the largest and most diverse datasets in pathology, including data from over 1,000 institutions around the globe. This helped us to receive the first ever FDA approval for an AI product in pathology. Paige has also received FDA-clearance for our digital viewer, FullFocus®, and CE-IVD and UKCA clearance for our diagnostic AI in prostate and breast cancer.
Paige has created a single solution to labs’ biggest pain points, supporting them in delivering more efficient diagnoses to better support their patients. Our web-based software platform puts advanced digital pathology tools together with Paige and third-party AI into the hands of pathologists, while maintaining the highest security and safety standards.
Headquartered in New York with an expansive global footprint, Paige is developing and delivering a new generation of solutions to support labs of all shapes and sizes. Our team is guided by our mission to transform the world of cancer care and pioneer the path forward in the burgeoning industries of digital pathology and AI.
